Twitxy Saved

Uwe Siebert

@UweSiebert9

Austria umit-tirol.at/iph Joined August 2020
1.3K Following 1.2K Followers 528 Posts

Latest posts 5

Uwe Siebert @UweSiebert9
🚨 Early booking ends in 3 days!
Register now for our 5-day ONLINE HTADS Course: “Causal Inference for Assessing Effectiveness in RWD & Clinical Trials”
📅 March 23–27, 2026 | Hosted by UMIT TIROL
🧑‍💻 Practical applications in R and Stata
Faculty: Uwe Siebert, Nick Latimer, Ellie Van Vogt, Ian White, and Feli Kuehne
Topics: DAGs, g-methods, Target Trial Emulation, Adjusting for treatment switching in trials, HTA recommendations, and more.
Information & Registration: htads.org
Advance your expertise in causal methods for real-world data and clinical research — secure your spot today!
Uwe Siebert @UweSiebert9
Build a solid foundation in Health Technology Assessment (HTA) with this introductory ISPOR short course designed for researchers, clinicians, industry professionals, and policy makers. Learn how new drugs, devices & public health interventions are evaluated for clinical, economic, ethical and social value through real-world examples. The course covers core HTA methods—from benefit-harm and economic assessment to ethics and policy—and offers practical tools you can apply immediately, even with little or no prior HTA experience.
ISPOR @ISPORorg Feb 5
Build your understanding of how health technologies are evaluated! Get an overview of #HTA principles, methods, and terminology. Details here >> ow.ly/w8if50Y8tQJ
View quoted post on X
Uwe Siebert @UweSiebert9
🚨 Few seats left – Early bird rates end January 5, 2026! 🚨
Step into the world of Health Technology Assessment (HTA) and Health Economics (HE) and join our comprehensive introductory 3-Day Certified University Course ‘Introduction to HTA and HE”, designed for professionals across healthcare, policy, industry, academia, and beyond – including a special session with an update on the new HTA regulation in Europe.
🔍 What to expect
This intensive course combines expert lectures, interactive discussions, and hands-on case study group work covering the key elements and methods of HTA and HE with theoretical foundations of Health Decision Science.
📚 Key topics include
Principles and practice of HTA & HE
Health outcomes, utilities, and the QALY concept
Cost-effectiveness, cost-utility, cost-benefit & budget impact analyses
Decision-analytic modelling (decision trees, Markov models, simulations)
Assessing and handling uncertainty
Pricing & reimbursement decisions (ICERs, thresholds)
Real-world evidence (RWE) in HTA, target trial emulation and causal inference
Critical appraisal of HE and HTA studies
European HTA landscape and good practice guidelines, including the new European HTA Regulation
Perspectives of agencies, industry, decision-makers, and patients
Breakout sessions with practical exercises on HTA reports and publications
🎯 Who should attend?
All stakeholders including healthcare & health policy organizations, national HTA agencies; pharmaceutical & medical device industry; academia & research institutions; health insurances / sickness funds; consultancy and contract research organizations; patient representatives, ...
✅ No pre-requisites required
This is an introductory course. The course language is English, and both native and non-native speakers are very welcome.
👩‍🏫Outstanding international faculty
Learn from leading experts in HTA, health economics, and medical decision-making with extensive experience across academia, policy, and practice.
📅 Secure your spot now and benefit from early bird rates until January 5, 2026.
Register here: umit-tirol.at/page.cfm?vpath…
👉 Interested or want more details? Get in touch or register soon—seats are limited!
#HealthTechnologyAssessment #HealthEconomics #HTA #HealthPolicy #MedicalDecisionMaking #EarlyCareer #ProfessionalDevelopment #HealthcareInnovation #htads
Uwe Siebert @UweSiebert9
🌍 Don’t miss the ISPOR Real-World Evidence Summit 2025 in Tokyo!
This landmark event with excellent speakers and presenters featured by short courses, workshops, issue panels, networking and breakout sessions, educational symposia and spotlights will highlight how the Asia Pacific region is transforming healthcare decision making through innovative applications of real-world evidence.
It’s a unique opportunity to gain fresh insights, exchange ideas with global experts, and help shape the future of health policy and practice.
I am very much looking forward to seeing you in Tokyo! 🇯🇵
👉 Don’t miss the early registration deadline (21 August)
ISPOR @ISPORorg Aug 19, 2025
The future of #RWE is being shaped in Asia Pacific. Join global leaders at the ISPOR RWE Summit 2025 in Tokyo! Details 👉 ow.ly/VZ2x50WGIAE
#HEOR #HealthcareInnovation
View quoted post on X